Literature DB >> 18510895

Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and Botswana.

Bisola Ojikutu1, A T Makadzange, Tendani Gaolathe.   

Abstract

Over the past 3 years, significant strides have been made in the effort to provide antiretroviral therapy (ART) to the millions of people worldwide who require treatment for HIV. In 2006, 1.3 million people had initiated ART in sub-Saharan Africa, which is a 10-fold increase over the number who had access to treatment 3 years prior. Although this progress should be acknowledged, achieving universal access will require much more work. As countries initiate large-scale treatment programs, many political, social, economic, and operational challenges have become evident. South Africa, Zimbabwe, and Botswana are three neighboring countries engaged in ART roll-out. This article describes the HIV epidemic in these three countries, details the most critical challenges inhibiting the progression of antiretroviral therapy roll-out, and highlights successes within each setting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18510895     DOI: 10.1007/s11904-008-0015-3

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  7 in total

1.  Establishment of a public antiretroviral treatment clinic for adults in urban Botswana: lessons learned.

Authors:  C William Wester; Hermann Bussmann; Ava Avalos; Ndwapi Ndwapi; Tendani Gaolathe; Peter Cardiello; Christine Bussmann; Howard Moffat; Patson Mazonde; Richard G Marlink
Journal:  Clin Infect Dis       Date:  2005-03-07       Impact factor: 9.079

2.  Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.

Authors:  C William Wester; Soyeon Kim; Hermann Bussmann; Ava Avalos; Ndwapi Ndwapi; Trevor F Peter; Tendani Gaolathe; Andrew Mujugira; Lesego Busang; Chris Vanderwarker; Peter Cardiello; Onalethata Johnson; Ibou Thior; Patson Mazonde; Howard Moffat; Max Essex; Richard Marlink
Journal:  J Acquir Immune Defic Syndr       Date:  2005-11-01       Impact factor: 3.731

3.  HIV decline associated with behavior change in eastern Zimbabwe.

Authors:  Simon Gregson; Geoffrey P Garnett; Constance A Nyamukapa; Timothy B Hallett; James J C Lewis; Peter R Mason; Stephen K Chandiwana; Roy M Anderson
Journal:  Science       Date:  2006-02-03       Impact factor: 47.728

4.  Age at first sex and HIV infection in rural Zimbabwe.

Authors:  Timothy B Hallett; James J C Lewis; Ben A Lopman; Constance A Nyamukapa; Phyllis Mushati; Mainford Wambe; Geoff P Garnett; Simon Gregson
Journal:  Stud Fam Plann       Date:  2007-03

5.  Recent multiple sexual partners and HIV transmission risks among people living with HIV/AIDS in Botswana.

Authors:  Seth C Kalichman; Dolly Ntseane; Keitseope Nthomang; Mosarwa Segwabe; Odireleng Phorano; Leickness C Simbayi
Journal:  Sex Transm Infect       Date:  2007-05-02       Impact factor: 3.519

6.  Successful introduction of routine opt-out HIV testing in antenatal care in Botswana.

Authors:  Tracy L Creek; Raphael Ntumy; Khumo Seipone; Monica Smith; Mpho Mogodi; Molly Smit; Keitumetse Legwaila; Iris Molokwane; Goitebetswe Tebele; Loeto Mazhani; Nathan Shaffer; Peter H Kilmarx
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

7.  Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

Authors:  Brian G Williams; Christopher Dye
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

  7 in total
  11 in total

1.  Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.

Authors:  Eugene Mutimura; Diane Addison; Kathryn Anastos; Donald Hoover; Jean Claude Dusingize; Ben Karenzie; Isabelle Izimukwiye; Leo Mutesa; Sabin Nsanzimana; Denis Nash
Journal:  AIDS       Date:  2015-01-02       Impact factor: 4.177

2.  Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis.

Authors:  Taraz Samandari; Tefera B Agizew; Samba Nyirenda; Zegabriel Tedla; Thabisa Sibanda; Barudi Mosimaneotsile; Oaitse I Motsamai; Nong Shang; Charles E Rose; James Shepherd
Journal:  AIDS       Date:  2015-01-28       Impact factor: 4.177

3.  A qualitative study of patient motivation to adhere to combination antiretroviral therapy in South Africa.

Authors:  Francois van Loggerenberg; Debra Gray; Santhanalakshmi Gengiah; Pinky Kunene; Tanuja N Gengiah; Kogieleum Naidoo; Alison D Grant
Journal:  AIDS Patient Care STDS       Date:  2015-02-18       Impact factor: 5.078

Review 4.  Overcoming Health System Challenges for Women and Children Living With HIV Through the Global Plan.

Authors:  Surbhi Modi; Tegan Callahan; Jessica Rodrigues; Mwikemo D Kajoka; Helen M Dale; Judite O Langa; Marilena Urso; Matsepeli I Nchephe; Helene Bongdene; Sostena Romano; Laura N Broyles
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

5.  Changing use of traditional healthcare amongst those dying of HIV related disease and TB in rural South Africa from 2003 - 2011: a retrospective cohort study.

Authors:  Paul Mee; Ryan G Wagner; Francesc Xavier Gómez-Olivé; Chodziwadziwa Kabudula; Kathleen Kahn; Sangeetha Madhavan; Mark Collinson; Peter Byass; Stephen M Tollman
Journal:  BMC Complement Altern Med       Date:  2014-12-17       Impact factor: 3.659

6.  Impact of a critical health workforce shortage on child health in Zimbabwe: a country case study on progress in child survival, 2000-2013.

Authors:  Connie A Haley; Sten H Vermund; Precious Moyo; Aaron M Kipp; Bernard Madzima; Trevor Kanyowa; Teshome Desta; Kasonde Mwinga; Marie A Brault
Journal:  Health Policy Plan       Date:  2017-06-01       Impact factor: 3.344

Review 7.  Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa.

Authors:  Natasha Croome; Monisha Ahluwalia; Lyndsay D Hughes; Melanie Abas
Journal:  AIDS       Date:  2017-04-24       Impact factor: 4.177

8.  Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Authors:  Elena Losina; Hapsatou Touré; Lauren M Uhler; Xavier Anglaret; A David Paltiel; Eric Balestre; Rochelle P Walensky; Eugène Messou; Milton C Weinstein; François Dabis; Kenneth A Freedberg
Journal:  PLoS Med       Date:  2009-10-27       Impact factor: 11.069

9.  Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy.

Authors:  Allan W Taylor; Barudi Mosimaneotsile; Unami Mathebula; Anikie Mathoma; Ritah Moathlodi; Irene Theebetsile; Taraz Samandari
Journal:  Infect Dis Obstet Gynecol       Date:  2013-03-07

10.  Evidence for localised HIV related micro-epidemics associated with the decentralised provision of antiretroviral treatment in rural South Africa: a spatio-temporal analysis of changing mortality patterns (2007-2010).

Authors:  Paul Mee; Mark A Collinson; Sangeetha Madhavan; Elisabeth Dowling Root; Stephen M Tollman; Peter Byass; Kathleen Kahn
Journal:  J Glob Health       Date:  2014-06       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.